<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202013000400004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Programa científico]]></article-title>
</title-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<fpage>11</fpage>
<lpage>32</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202013000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202013000400004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202013000400004&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[   <basefont size="3">     <p align="left"><font face="Verdana" size="2"> Programa cient&iacute;fico&nbsp; </font></p>      <p align="left"><b><font face="Verdana" size="4"> Programa cient&iacute;fico    <br>  &nbsp; </font></b></p>      <p align="left"><font face="Verdana" size="2"> <b>Domingo 1 de diciembre&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n Ball Room A&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 16.50<b>&nbsp;&nbsp;&nbsp;&nbsp;Curso Pre Congreso &ndash; EMC &ndash; Parte I&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a no invasiva en cardiopat&iacute;a isqu&eacute;mica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Bayer    <br>  &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Oscar Bazzino, Dr. Ricardo Lluberas,  Dr. Gustavo Vignolo&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;14.00 &ndash; 14.05&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Lluberas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 1    <br>  </b>&nbsp;&nbsp;&nbsp;&nbsp;<b>Imagenolog&iacute;a en la fase asintom&aacute;tica de la cardiopat&iacute;a isqu&eacute;mica.  Paciente con factores de riesgo&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinador: Dr. Ricardo Lluberas&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14.05 &ndash; 14.10&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico    <br>   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dr. Sebasti&aacute;n Albistur, Dr. Mart&iacute;n  Andurskevicius&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.10 &ndash; 14.20&nbsp;&nbsp;&nbsp;&nbsp;Espesor &iacute;ntima media: contribuci&oacute;n a la valoraci&oacute;n de riesgo    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra.  Yanina Z&oacute;calo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.20 &ndash; 14.30&nbsp;&nbsp;&nbsp;&nbsp;Score de calcio: contribuci&oacute;n a la valoraci&oacute;n de riesgo&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Acu&ntilde;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.30 &ndash; 14.45&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Marcelo Di Carli (USA), Dr. Jos&eacute; Anibal Manfredi,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.  Horacio V&aacute;zquez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;M&Oacute;DULO 2&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a en la angina cr&oacute;nica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.45 &ndash; 14.50&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dra. Luciana Jubany, Dr. Mart&iacute;n del Castillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.50 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;Eco stress en la angina cr&oacute;nica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Bautista Gonz&aacute;lez Moreno&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.10&nbsp;&nbsp;&nbsp;&nbsp;Medicina nuclear en la angina cr&oacute;nica: nuevas modalidades&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sergio Vi&ntilde;as&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.10 &ndash; 15.20&nbsp;&nbsp;&nbsp;&nbsp;RNM de stress para la detecci&oacute;n de isquemia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.20 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a no invasiva en el paciente revascularizado&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.30 &ndash; 15.50&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Marcelo Di Carli (USA), Dr. Fernando Kuster, Dr. Roberto  Ricca,    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Horacio V&aacute;zquez&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 3&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a en la evaluaci&oacute;n del dolor tor&aacute;cico&nbsp;&nbsp;&nbsp;&nbsp;</b>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Oscar  Bazzino&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15.50 &ndash; 15.55&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dra. Natalia Esmite, Dr. Gerardo Conti&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.55 &ndash; 16.05 &nbsp;&nbsp;&nbsp;&nbsp;Ecocardiograf&iacute;a en el dolor tor&aacute;cico. Rendimiento diagn&oacute;stico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.05 &ndash; 16.15&nbsp;&nbsp;&nbsp;&nbsp;Estudios de medicina nuclear en la evaluaci&oacute;n del dolor tor&aacute;cico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Mario Beretta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.15 &ndash; 16.20&nbsp;&nbsp;&nbsp;&nbsp;Tomograf&iacute;a multicorte en el paciente con dolor tor&aacute;cico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Julia Aramburu&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.20 &ndash; 16.50&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Sergio Burguez , Dr. Marcelo Di Carli (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.50 &ndash; 17.20&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 17.20 &ndash; 18.55&nbsp;&nbsp;&nbsp;&nbsp;<b>Curso Pre Congreso &ndash; EMC &ndash; Parte II&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a no invasiva en cardiopat&iacute;a isqu&eacute;mica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Oscar Bazzino, Dr. Ricardo Lluberas, Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>M&Oacute;DULO 4&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Imagenolog&iacute;a en la fase de miocardiopat&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Oscar Bazzino, Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.20 &ndash; 17.25&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dr. Rodrigo Abreu, Dra. Marcela Delpiano&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.25 &ndash; 17.35&nbsp;&nbsp;&nbsp;&nbsp;Ecocardiograf&iacute;a en la cardiopat&iacute;a dilatada: funci&oacute;n ventricular y     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;viabilidad mioc&aacute;rdica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Enrique Dom&iacute;nguez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.35 &ndash; 17.50&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia mitral funcional. Valoraci&oacute;n ecocardiogr&aacute;fica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sergio Burguez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.50 &ndash; 18.10&nbsp;&nbsp;&nbsp;&nbsp;Viabilidad mioc&aacute;rdica y medicina nuclear (PET)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Mariela Lujambio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;18.10 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;RNM: caracterizaci&oacute;n tisular y viabilidad mioc&aacute;rdica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Natalia Lluberas&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;18.30 &ndash; 18.55&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Pablo Alvarez Rocha, Dr. Enrique Besada, Dr. Sergio Burguez,      <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Marcelo Di Carli (USA), Dr. Carlos Gonz&aacute;lez Tr&iacute;as, Dr. Alvaro Lorenzo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 18.55 &ndash; 19.25&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Rol de la imagenolog&iacute;a card&iacute;aca no invasiva en el manejo del paciente con  enfermedad     <br>  &nbsp;&nbsp;&nbsp;&nbsp;coronaria: &iquest;qui&eacute;n, cu&aacute;ndo y c&oacute;mo?</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. Marcelo Di Carli (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Ricardo Lluberas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 19.25 &ndash; 19.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Evaluaci&oacute;n final del curso&nbsp;</b> </font></p>     <p align="left"><font face="Verdana" size="2"> <b>Lunes 2 de diciembre&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room A&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa &nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;El paciente a&ntilde;oso en cardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Bernardo Layerle, Dr. Washington Vignolo&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.10&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n integral del adulto mayor&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Aldo Fierro&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.10 &ndash; 08.22&nbsp;&nbsp;&nbsp;&nbsp;Hipertensi&oacute;n arterial en el a&ntilde;oso&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Bernardo Layerle&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.22 &ndash; 08.34&nbsp;&nbsp;&nbsp;&nbsp;Estenosis a&oacute;rtica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Anibal Manfredi&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.34 &ndash; 08.46&nbsp;&nbsp;&nbsp;&nbsp;Fibrilaci&oacute;n auricular&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Washington Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.46 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;Casos cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 09.30 &ndash; 10.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Manejo de los s&iacute;ndromes coronarios agudos en los ancianos</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Dr. H&eacute;ctor Bueno (Espa&ntilde;a)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Joaqu&iacute;n Cobas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa &nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Valvulopat&iacute;a a&oacute;rtica&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Enrique Dom&iacute;nguez, Dr. Horacio V&aacute;zquez</i>    <br>  &nbsp;&nbsp;&nbsp;&nbsp;<b>Auspicia: Instituto  Nacional de Cirug&iacute;a Card&iacute;aca</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.50&nbsp;&nbsp;&nbsp;&nbsp;Conceptos actuales sobre el tratamiento de la estenosis a&oacute;rtica calcificada.    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oportunidad y opciones para la intervenci&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Catherine Otto (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.50 &ndash; 11.10&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia valvular a&oacute;rtica severa asintom&aacute;tica o sintom&aacute;tica: nunca es     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;demasiado temprano o demasiado tarde para intervenir&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Robert Bonow (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.10 &ndash; 11.25&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a no convencional de la valvulopat&iacute;a a&oacute;rtica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Luiz Lisboa (Brasil)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.25 &ndash; 11.40&nbsp;&nbsp;&nbsp;&nbsp;TAVI. Consideraciones t&eacute;cnicas del implante percut&aacute;neo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jorge Belardi (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.40 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Avances en el diagn&oacute;stico y el tratamiento de la estenosis a&oacute;rtica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Dr. Robert Bonow (USA)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Alfredo &Aacute;lvarez Rocha<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Intervalo &ndash; Actividad en Sala Conference<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa Conjunta SUC &ndash; Sociedad de Neurolog&iacute;a del Uruguay &ndash;     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Sociedad  Uruguaya de Medicina Intensiva&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardioembolia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pablo Asadurian, Dr. Fabi&aacute;n Mart&iacute;nez</i>&nbsp; </font></p>      <p align="left"> <font face="Verdana" size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Pfizer</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.15&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Por qu&eacute; solicitar un ETE al paciente con ACV?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 &ndash; 14.40&nbsp;&nbsp;&nbsp;&nbsp;Manejo de la anticoagulaci&oacute;n oral en la prevenci&oacute;n de la cardioembolia.     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Escenarios especiales&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo Asadurian&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.40 &ndash; 14.58&nbsp;&nbsp;&nbsp;&nbsp;Reperfusi&oacute;n en el ACV hiperagudo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Andr&eacute;s Gay&eacute;&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.58 &ndash; 15.10&nbsp;&nbsp;&nbsp;&nbsp;ACV en el paciente anticoagulado&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Leandro Moraes&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.10 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Fibrilaci&oacute;n auricular: nuevos anticoagulantes&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Arturo Cagide (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 15.30 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia de apertura&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Las estrategias de tratamiento para los pacientes con insuficiencia card&iacute;aca  de causa isqu&eacute;mica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Robert Bonow (USA)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Gustavo Junker&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndromes coronarios agudos con ST&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Frank Torres, Dr. Pedro Trujillo&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;Angioplastia en el SCA con ST&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jorge Belardi (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Qu&eacute; aprendimos del PIAM?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo D&iacute;az, Dr. Alvaro Niggemeyer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;Estrategia de antiagregaci&oacute;n en el 2013 para los SCA con ST elevado.     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Antiagregantes: &iquest;cu&aacute;les, a qui&eacute;n, cu&aacute;ndo y c&oacute;mo?&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Fabio Brito (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 18.00 &ndash; 18.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Los avances en cardiolog&iacute;a nuclear para mejorar el diagn&oacute;stico y manejo      <br>  &nbsp;&nbsp;&nbsp;&nbsp;de la enfermedad coronaria&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;</b><i>Dr. Marcelo Di Carli (USA)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Enrique Besada <b>&nbsp;</b> </font></p>       <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Conference&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;<b>2&deg; Simposio Conjunto SUC &ndash; Federaci&oacute;n Argentina de Cardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Insuficiencia card&iacute;aca&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Pablo Alvarez Rocha, Dra. Virginia Estrag&oacute;</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidentes: Dra. Laura Sanziani (Argentina), Dra. M&oacute;nica Giambruno&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.15&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n de los resultados de la fase uruguaya del Registro Europeo de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia Card&iacute;aca - GUERNICA&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Virginia Estrag&oacute;&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 &ndash; 08.35&nbsp;&nbsp;&nbsp;&nbsp;Manejo de la Insuficiencia Card&iacute;aca. Novedades de las Gu&iacute;as de la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sociedad Europea de Cardiolog&iacute;a 2012&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Aldo Maggioni (Italia)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.35 &ndash; 08.45&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Andreina G&oacute;mez&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 &ndash; 09.05&nbsp;&nbsp;&nbsp;&nbsp;Detectando Isquemia y viabilidad en Insuficiencia Card&iacute;aca. &iquest;Qu&eacute; nos ense&ntilde;&oacute;     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;el estudio STICH?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Marcelo Di Carli (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.05 &ndash; 09.15&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Torrado&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia card&iacute;aca aguda. Nueva clasificaci&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. C&eacute;sar Belziti (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Las deficiencias en el manejo cl&iacute;nico de la falla card&iacute;aca aguda hoy: &iquest;cu&aacute;les  son las     <br>  &nbsp;&nbsp;&nbsp;&nbsp;diferencias entre las directrices y la pr&aacute;ctica cl&iacute;nica?&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dr. Aldo Maggioni (Italia)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Fernando Kuster&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Evaluaci&oacute;n cardiol&oacute;gica del deportista. Prevenci&oacute;n de muerte s&uacute;bita&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Oscar D&iacute;az Arnesto, Dr. Alejandro Cuesta</i>    <br>  &nbsp;&nbsp;&nbsp;&nbsp;<b>Auspicia: Arcos  Medical - Medtronic</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.50&nbsp;&nbsp;&nbsp;&nbsp;Epidemiolog&iacute;a y causas de MS del deportista&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Laura Sanziani (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.50 &ndash; 11.10&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n pre-deportiva y ECG&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Stein (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.10 &ndash; 11.20&nbsp;&nbsp;&nbsp;&nbsp;DEA. Legislaci&oacute;n y experiencia nacional&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Alvaro Niggemeyer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.20 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;Experiencia nacional. PREMUDE&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sergio Giovanetti&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 11.40&nbsp;&nbsp;&nbsp;&nbsp;Caso Cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Cuesta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.40 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Qu&eacute; visi&oacute;n tienen sobre el problema de la MS en el deporte?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Moderador: Dr. Oscar D&iacute;az Arnesto&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deportista: Sr. Fernando Alvez&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deport&oacute;logos: Dr. Milton Massa, Dr. Daniel Zarrillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Periodista: Prof. Ricardo Pi&ntilde;eyr&uacute;a&nbsp; </font></p>       <p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pol&iacute;tico: Dr. H&eacute;ctor Lescano&nbsp;    <br> </font> </p>     <p align="left"><font face="Verdana" size="2"> 12.00 &ndash; 12.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n cardiol&oacute;gica del deportista. Prevenci&oacute;n de muerte s&uacute;bita&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Dra. Laura Sanziani (Argentina)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Walter Reyes Caorsi&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Simposio Boehringer Ingelheim&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nuevos anticoagulantes y FA: el futuro en la prevenci&oacute;n del ACV ya es  el presente&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Coordinador: Dr. Luis Aguinaga (Argentina)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.30 &ndash; 13.00&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n. Nuevos anticoagulantes en la prevenci&oacute;n del ACV relacionado a FA&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i>Dr. Luis Aguinaga (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.00 &ndash; 13.20&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Luis Aguinaga (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Pablo Mux&iacute;, Dr. Horacio V&aacute;zquez, Dra. Claudia Camejo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.20 &ndash; 13.30&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Lunch cortes&iacute;a Boehringer Ingelheim&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 15.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Arritmias ventriculares en policl&iacute;nica. &iquest;A qui&eacute;n, c&oacute;mo y cu&aacute;ndo tratar?&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dra. Beatriz Ans&iacute;n, Dr. Ricardo Lorenzo&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Discusi&oacute;n de casos cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dra. Beatriz Ans&iacute;n, Dr. Alejandro Cuesta, Dr. Juan Keushkerian,    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra.  Ver&oacute;nica P&eacute;rez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Jos&eacute; Luis Gonz&aacute;lez (Argentina), Dra. Laura Sanziani (Argentina),    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr.  Juan Viles Gonz&aacute;lez (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 15.30 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa Conjunta SUC &ndash; Sociedad Uruguaya de Nefrolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Interacci&oacute;n cardiorrenal&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dra. Zuly Cortellezzi, Dr. Jos&eacute; Carlos Silva&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;Epidemiolog&iacute;a de la enfermedad renal. Presentaci&oacute;n del Programa     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de Salud Renal en Uruguay&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Asunci&oacute;n Alvarez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;El ri&ntilde;&oacute;n para el cardi&oacute;logo: un problema&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Zuly Cortellezzi, Dr. Jos&eacute; Carlos Silva&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 17.50&nbsp;&nbsp;&nbsp;&nbsp;Aspectos puntuales de la interacci&oacute;n cardiorrenal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Asunci&oacute;n Alvarez, Dr. Oscar Noboa, Dra. Zuly Cortellezzi,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute;  Carlos Silva&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.50 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> 18.00 &ndash; 18.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Papel de la revascularizaci&oacute;n coronaria en pacientes con disfunci&oacute;n ventricular  izquierda severa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Dr. H&eacute;ctor Bueno (Espa&ntilde;a)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Nicol&aacute;s Russo&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Picasso&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Curso&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Anatom&iacute;a aplicada a la cardiolog&iacute;a cl&iacute;nica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadores: Dr. Juan Keushkerian, Dr. Alvaro Rivara&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Docentes: Dra. Alejandra Neirreiter, Dra. Virginia Cuello, Dra. Natalia  L&oacute;pez,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dra. Gabriela Aguiar, Dr. Santiago Pose, Dra. Cecilia Santos, Dra.  Mar&iacute;a Elena Vergara,     ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;Dra. Ver&oacute;nica de los Santos, Dr. Alejandro Russo,  Dr. Diego Alvarez, Dra. Emilia Cerchiari,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan del Castillo, Dr. Joaqu&iacute;n  Garc&iacute;a, Dr. Gabriel Parma, Dr. Carlos Am&eacute;rico,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Alejandro Gonz&aacute;lez,  Dr. Alvaro Marichal, Dr. Fabi&aacute;n Mart&iacute;nez, Dra. Valentina Agorrody,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr.  Diego Capurro, Dr. Rafael Mila, Dr. Juan Pablo Bachini, Dra. Dayana Acosta,      <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Federico Ferrando&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.30&nbsp;&nbsp;&nbsp;&nbsp;M&oacute;dulo Ecocardiograf&iacute;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.30 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;M&oacute;dulo Cirug&iacute;a Card&iacute;aca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Fabio Guti&eacute;rrez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;M&oacute;dulo Electrofisiolog&iacute;a&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Juan Keushkerian&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;M&oacute;dulo Hemodinamia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: &nbsp;Dr. Pedro Trujillo, Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A y Conference&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Conference<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio &nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Comit&eacute; Imagen Cardiovascular&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadora: Dra. Ver&oacute;nica Gonz&aacute;lez    <br>  &nbsp;&nbsp;&nbsp;&nbsp;</i><b>Auspicia: Qu&iacute;mica Cenit</b><i>&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.30&nbsp;&nbsp;&nbsp;&nbsp;Desaf&iacute;os en la valoraci&oacute;n de la estenosis a&oacute;rtica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Catherine Otto (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;Valor de la ecocardiograf&iacute;a en la insuficiencia card&iacute;aca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Marcia Barbosa (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Enfermedades del pericardio estudiadas desde las multiim&aacute;genes&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Obreg&oacute;n (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 15.30 &ndash; 16.00 &nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Comit&eacute; Imagen Cardiovascular - Continuaci&oacute;n&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;Aportes de la cardioresonancia en el estudio y valoraci&oacute;n de la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cardiopat&iacute;a isqu&eacute;mica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Gonz&aacute;lez Tr&iacute;as&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>       <p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Le&oacute;n Mu&ntilde;oz<b>&nbsp;</b>&nbsp;</font></p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: C&eacute;zanne&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Cardiolog&iacute;a Cl&iacute;nica&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Juan Krauss (Argentina), Dr. Oscar Bazzino&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;8&nbsp;&nbsp;&nbsp;&nbsp;Incidencia y severidad de las alteraciones del metabolismo fosfoc&aacute;lcico    ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en pacientes hipertensos refractarios de alto riesgo cl&iacute;nico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martir&eacute;&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 &ndash; 08.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;15&nbsp;&nbsp;&nbsp;&nbsp;Venta de f&aacute;rmacos antihipertensivos e hipertensos tratados en Uruguay&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Edgardo Sandoya&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 &ndash; 08.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;16&nbsp;&nbsp;&nbsp;&nbsp;Prevalencia de la fibrilaci&oacute;n auricular en la poblaci&oacute;n adulta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Mar&iacute;a del Pilar Aguilar&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;24&nbsp;&nbsp;&nbsp;&nbsp;Primer reporte de un caso de endocarditis por <i>Brahamanella  catarralis</i>     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en Uruguay&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Andrea Pertierra&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Ricardo Lorenzo , Dr. Marcelo Llancaqueo (Chile)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;25&nbsp;&nbsp;&nbsp;&nbsp;Endocarditis asociada a dispositivos intracardiacos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Ignacio Tourn&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;27&nbsp;&nbsp;&nbsp;&nbsp;Calidad de la anticoagulaci&oacute;n oral en Policl&iacute;nica de Cardiolog&iacute;a:     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;porcentaje de tiempo en rango terap&eacute;utico&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Andreina G&oacute;mez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.30 &ndash; 09.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;34&nbsp;&nbsp;&nbsp;&nbsp;Calidad de vida relacionada al estado de salud a trav&eacute;s de cuestionarios    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SF-36 y DASI en el pre operatorio de CRM&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Natalia Esmite&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.45 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;41&nbsp;&nbsp;&nbsp;&nbsp;Utilizaci&oacute;n de drogas antihipertensivas en una IAMC de Montevideo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Horacio V&aacute;zquez&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Hemodinamia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dra. Lorena Villalba (Paraguay), Dr. Pablo V&aacute;zquez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;20&nbsp;&nbsp;&nbsp;&nbsp;Cambios demogr&aacute;ficos de la poblaci&oacute;n asistida con angioplastia primaria    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;en una d&eacute;cada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Carolina Artucio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.45 &ndash; 11.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;21&nbsp;&nbsp;&nbsp;&nbsp;Predictores de &eacute;xito del procedimiento de tromboaspiraci&oacute;n en el IAM&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Leandro Jubany&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.00 &ndash; 11.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;26&nbsp;&nbsp;&nbsp;&nbsp;Radioprotecci&oacute;n en procedimientos coronarios intervencionistas:     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;estudio randomizado comparativo sobre el efecto de la protecci&oacute;n     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;p&eacute;lvica  del paciente. Estudio 4P.&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;30&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento de la restenosis coronaria con bal&oacute;n liberador de paclitaxel:    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;seguimiento cl&iacute;nico, angiogr&aacute;fico y ultrasonograf&iacute;a intravascular.     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estudio TREPA&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Andr&eacute;s Tuzman, Dr. Pablo D&iacute;az&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 11.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;38&nbsp;&nbsp;&nbsp;&nbsp;Auditor&iacute;a acad&eacute;mica de las angiograf&iacute;as coronarias sin lesiones     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;epic&aacute;rdicas significativas en un servicio de hemodinamia universitario.    ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Etapa  I: an&aacute;lisis de las indicaciones del procedimiento&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerardo Conti&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.45 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;43&nbsp;&nbsp;&nbsp;&nbsp;ATC con implante de stent sobre una compleja lesi&oacute;n de TCI. Estrategia    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;terap&eacute;utica basada en el uso de IVUS&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Pablo Bachini&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.00 &ndash; 12.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;46&nbsp;&nbsp;&nbsp;&nbsp;Reporte de un caso de implante percut&aacute;neo valvular a&oacute;rtico por acceso    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no convencional en paciente con acceso a&oacute;rtico-il&iacute;aco hostil&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.15 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;47&nbsp;&nbsp;&nbsp;&nbsp;Reporte de un caso cl&iacute;nico de f&iacute;stula arterio-venosa de arteria mamaria     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;interna derecha a vena mamaria interna derecha secundaria a CRM&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Conference&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Prevenci&oacute;n y Rehabilitaci&oacute;n&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Carlos Berm&uacute;dez, Dr. Ricardo Bachmann&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;2&nbsp;&nbsp;&nbsp;&nbsp;Los marcadores vasculares carot&iacute;deos mejoran la predicci&oacute;n de riesgo del    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;score de Framingham en pacientes asintom&aacute;ticos, a mediano plazo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martir&eacute;&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 &ndash; 14.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;17&nbsp;&nbsp;&nbsp;&nbsp;Mortalidad y sus causas en pacientes coronarios en un programa de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prevenci&oacute;n secundaria&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerard Burdiat&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 &ndash; 14.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;22&nbsp;&nbsp;&nbsp;&nbsp;Actividad f&iacute;sica en pacientes participantes de un programa de prevenci&oacute;n    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;secundaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Lic. Jorge Tejada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.45 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;29&nbsp;&nbsp;&nbsp;&nbsp;Efecto del g&eacute;nero en el cumplimiento de los objetivos de prevenci&oacute;n     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;secundaria en una poblaci&oacute;n con cardiopat&iacute;a isqu&eacute;mica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Lorena Vi&ntilde;ole Clavijo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;53&nbsp;&nbsp;&nbsp;&nbsp;Prevalencia de aterosclerosis subcl&iacute;nica y reclasificaci&oacute;n de riesgo en     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;trabajadores agropecuarios: an&aacute;lisis de carga/exigencia laboral&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Nuri Stolovas&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.15 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;58&nbsp;&nbsp;&nbsp;&nbsp;Consumo de frutas y verduras en pacientes de un programa de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prevenci&oacute;n secundaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Lic. Nut. Daniel Prendez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 &ndash; 15.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;59&nbsp;&nbsp;&nbsp;&nbsp;Reclasificaci&oacute;n del riesgo cardiovascular en una poblaci&oacute;n uruguaya     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;asintom&aacute;tica, mediante utilizaci&oacute;n de estudios arteriales no-invasivos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador:Lic. Marcelo Berm&uacute;dez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Cardiolog&iacute;a Cl&iacute;nica</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Sergio Meirelles, Dr. Enrique Besada&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 16.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;50&nbsp;&nbsp;&nbsp;&nbsp;Prevalencia e incidencia de fibrilaci&oacute;n auricular en una poblaci&oacute;n de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pacientes con disfunci&oacute;n sist&oacute;lica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Paolo Acosta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.45 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;55&nbsp;&nbsp;&nbsp;&nbsp;Evoluci&oacute;n a mediano plazo de pacientes con angor estable y prueba     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;funcional positiva en ausencia de lesiones coronarias angiogr&aacute;ficamente    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;significativas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Diana Sasso&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 17.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;57&nbsp;&nbsp;&nbsp;&nbsp;Miocardiopat&iacute;a Hipertr&oacute;fica: Descripci&oacute;n de sus caracter&iacute;sticas y riesgo    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de muerte s&uacute;bita en una poblaci&oacute;n asistida en policl&iacute;nica especializada&nbsp; </font></p>       <p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Alicia Torterolo&nbsp;    ]]></body>
<body><![CDATA[<br> </font> </p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.15 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;61&nbsp;&nbsp;&nbsp;&nbsp;Estructura y funci&oacute;n arterial en pacientes con disfunci&oacute;n ventricular     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;izquierda: diferencias seg&uacute;n etiolog&iacute;a y tiempo de presentaci&oacute;n de la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cardiopat&iacute;a isqu&eacute;mica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Sebasti&aacute;n Albistur&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 17.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;67&nbsp;&nbsp;&nbsp;&nbsp;</font><font color="#000000" face="Verdana" size="2">Asociaci&oacute;n de ancho de distribuci&oacute;n eritrocitaria y el  NT-proBNP en     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pacientes portadores de insuficiencia cardiaca con disfunci&oacute;n sist&oacute;lica&nbsp;</font><font face="Verdana" size="2"> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 18.00 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A y Conference&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Matisse&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Electrofisiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Alejandro Cuesta, Dr. Jos&eacute; Luis Gonz&aacute;lez (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;4&nbsp;&nbsp;&nbsp;&nbsp;Abordaje transeptal &ldquo;simplificado&rdquo; para la ablaci&oacute;n transcat&eacute;ter de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sustratos arritmog&eacute;nicos auriculares izquierdos. Experiencia de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;nuestro  centro.&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ricardo Ferrer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 &ndash; 08.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;42&nbsp;&nbsp;&nbsp;&nbsp;S&iacute;ndrome de Brugada y CDAI. Supervivencia libre de choques apropiados&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Marcela Delpiano&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 &ndash; 08.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;44&nbsp;&nbsp;&nbsp;&nbsp;Ablaci&oacute;n de la fibrilaci&oacute;n auricular (FA) guiada por sistema de mapeo     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tridimensional electroanat&oacute;mico. Experiencia inicial&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Marcela Delpiano&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;51&nbsp;&nbsp;&nbsp;&nbsp;Enfermedad del sistema de conducci&oacute;n como predictor del implante de    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;marcapasos definitivo en postoperatorio de sustituci&oacute;n valvular a&oacute;rtica    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;aislada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alex Rocha&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;56&nbsp;&nbsp;&nbsp;&nbsp;Bloqueo de rama alternante taquicardia-dependiente en un caso de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cardiopat&iacute;a isqu&eacute;mica avanzada con severa disfunci&oacute;n sist&oacute;lica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Vidal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;74&nbsp;&nbsp;&nbsp;&nbsp;Incidencia temporal de los ritmos desfibrilables y su supervivencia en el    ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;paro cardiaco extra hospitalario en Montevideo, Uruguay&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Federico Machado&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>S&iacute;ndrome Coronario Agudo&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Arturo Cagide (Argentina), Dr. Fernando Kuster&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;7&nbsp;&nbsp;&nbsp;&nbsp;</font><font color="#000000" face="Verdana" size="2">Evoluci&oacute;n contempor&aacute;nea del s&iacute;ndrome de Wellens: impacto  de las     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;estrategias terap&eacute;uticas actuales&nbsp;</font><font face="Verdana" size="2"> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Flavia Bilancieri&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.45 &ndash; 11.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;9&nbsp;&nbsp;&nbsp;&nbsp;Disecci&oacute;n coronaria espont&aacute;nea como causa de SCA&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Sebasti&aacute;n Albistur&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.00 &ndash; 11.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;19&nbsp;&nbsp;&nbsp;&nbsp;An&aacute;lisis descriptivo y predictores independientes de revascularizaci&oacute;n en&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;una poblaci&oacute;n de pacientes con S&iacute;ndrome Coronario Agudo sin elevaci&oacute;n    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;del  ST&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Valentina Lanz&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;23&nbsp;&nbsp;&nbsp;&nbsp;Primer Reporte de S&iacute;ndrome de Kounis en Uruguay (Infarto Al&eacute;rgico)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Virginia Beneditto&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Gonzalo Varela, Dr. Omar Montes De Oca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 11.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;35&nbsp;&nbsp;&nbsp;&nbsp;Ausencia de perfusi&oacute;n mioc&aacute;rdica precoz y paradojal en un caso de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;miocardiopat&iacute;a de takotsubo. Hallazgos a favor de una disfunci&oacute;n     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;microvascular coronaria severa asociada al estr&eacute;s.&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Rodrigo D&iacute;az&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.45 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;39&nbsp;&nbsp;&nbsp;&nbsp;Infarto agudo de miocardio inducido por terazosina en un paciente con     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cardiopat&iacute;a estructural predisponente&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Vidal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.00 &ndash; 12.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;68&nbsp;&nbsp;&nbsp;&nbsp;Estrategia invasiva precoz en el S&iacute;ndrome Coronario Agudo sin elevaci&oacute;n    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;del ST&nbsp; </font></p>       <p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Dayana Acosta&nbsp;&nbsp;</font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.15 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;69&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Cu&aacute;l es el tiempo &oacute;ptimo de hospitalizaci&oacute;n en S&iacute;ndromes Coronarios     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Agudos con sobreelevaci&oacute;n del ST Killip y Kimbal I y II?&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Mar&iacute;a Jos&eacute; Sommer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Conference&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A y Conference&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;</i><b>Cirug&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Rafael Arcos Rend&oacute;n (Ecuador), Dr. Luiz Lisboa (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 16.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;5&nbsp;&nbsp;&nbsp;&nbsp;Factores preoperatorios determinantes de mortalidad y estad&iacute;a     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prolongada en pacientes octogenarios sometidos a cirug&iacute;a de reemplazo    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;valvular  a&oacute;rtico por estenosis valvular&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ricardo Ferrer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.45 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;18&nbsp;&nbsp;&nbsp;&nbsp;Supervivencia en los mayores de 75 a&ntilde;os que aceptan o rechazan la     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cirug&iacute;a de revascularizaci&oacute;n mioc&aacute;rdica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Florencia Di Landro&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 17.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;31&nbsp;&nbsp;&nbsp;&nbsp;La cirug&iacute;a de revascularizaci&oacute;n mioc&aacute;rdica utilizando las dos arterias     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mamarias internas esqueletizadas es segura en pacientes  con diabetes    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mellitus&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Luc&iacute;a Dalto&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.15 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;54&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n mioc&aacute;rdica con ambas arterias mamarias internas     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;esqueletizadas. Experiencia inicial de un centro universitario de cirug&iacute;a     ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;card&iacute;aca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gerardo Soca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 17.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;66&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a mini invasiva para la sustituci&oacute;n valvular a&oacute;rtica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alvaro Marichal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 18.00 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A y Conference&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room C&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A, Conference y Picasso<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i><b>Comit&eacute; Cardiolog&iacute;a Nuclear&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Mario Beretta, Dr. Sergio Vi&ntilde;as</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 11.00&nbsp;&nbsp;&nbsp;&nbsp;Las fortalezas de la evaluaci&oacute;n funcional actual en la cardiopat&iacute;a isqu&eacute;mica     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cr&oacute;nica: &iquest;son suficientes?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Susana Zeffiro (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.00 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dra. Cecilia Bentancourt, Dr. Nicol&aacute;s Niell, Dr. Miguel Kapit&aacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;Cuantificaci&oacute;n del monto ventricular isqu&eacute;mico en la toma de decisiones:     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ventajas, limitaciones y nuevas metodolog&iacute;as&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Marcelo Di Carli (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Conference<b>&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 15.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Implante de v&aacute;lvula a&oacute;rtica (TAVI): una t&eacute;cnica en expansi&oacute;n en el mundo&hellip;  &iquest;y en Uruguay?&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Jorge Mayol, Dr. Juan Jos&eacute; Paganini&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Auspicia: Qualmed &ndash; Medtronic</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.05&nbsp;&nbsp;&nbsp;&nbsp;Introducci&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.05 &ndash; 14.25&nbsp;&nbsp;&nbsp;&nbsp;&iquest;C&oacute;mo evaluamos el riesgo de intervenir en la estenosis a&oacute;rtica?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Krauss (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.25 &ndash; 14.45&nbsp;&nbsp;&nbsp;&nbsp;Selecci&oacute;n de pacientes y resultados de TAVI&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Fabio Brito (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.45 &ndash; 15.05&nbsp;&nbsp;&nbsp;&nbsp;TAVI: la visi&oacute;n del cirujano&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Luiz Lisboa (Brasil)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.05 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n de experiencias nacionales&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Jorge Belardi (Argentina), Dr. Sergio Burguez,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos  Nojek (Argentina), Dr. Hugo Montero, Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 15.30 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;SUC &ndash; Sociedad Latinoamericana de Estimulaci&oacute;n Card&iacute;aca y Electrofisiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Coordinadores: Dr. Luis Aguinaga (Argentina), Dr. Gustavo Olveira</i>    <br>  <b>&nbsp;&nbsp;&nbsp;&nbsp;Auspicia:  Geoban &ndash; St. Jude Medical</b>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 16.50&nbsp;&nbsp;&nbsp;&nbsp;Ablaci&oacute;n de taquicardia ventricular en pacientes portadores de CDI. &iquest;Cu&aacute;ndo y     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c&oacute;mo?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Luis Gonz&aacute;lez (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;16.50 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dra. Beatriz Ans&iacute;n, Dr. Alejandro Vidal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Jos&eacute; Luis Gonz&aacute;lez (Argentina), Dr. Juan Viles Gonz&aacute;lez (USA),    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Palmira Vanzini, Dr. Gabriel Vanerio, Dr. Alvaro Rivara&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 17.50&nbsp;&nbsp;&nbsp;&nbsp;Ablaci&oacute;n de fibrilaci&oacute;n auricular en el 2013: del consultorio al laboratorio de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;electrofisiolog&iacute;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Viles Gonz&aacute;lez (USA)&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.50 &ndash; 18.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadores: Dr. Fabi&aacute;n Mart&iacute;nez, Dr. Gustavo Tortajada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Jos&eacute; Luis Gonz&aacute;lez (Argentina), Dr. Juan Viles Gonz&aacute;lez (USA),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Walter Reyes Caorsi, Dr. Diego Freire&nbsp;&nbsp;</font></p>     <p align="left">&nbsp;</p>     <p align="left"><font face="Verdana" size="2"> <b>Martes 3 de diciembre&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room A&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 09.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia mitral: desde el diagn&oacute;stico a la intervenci&oacute;n&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Coordinadores: Dra. Daniela Barranco, Dr. Sergio Burguez&nbsp;</i> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.20&nbsp;&nbsp;&nbsp;&nbsp;Aspectos diagn&oacute;sticos ecogr&aacute;ficos de insuficiencia mitral degenerativa y     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;funcional, aspectos diferenciales, criterios de severidad,  tips diagn&oacute;sticos,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;estudios especiales, ejercicio 3D&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Catherine Otto (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.20 &ndash; 08.40&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia mitral: manejo basado en la evidencia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Robert Bonow (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.40 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;Cirug&iacute;a conservadora en la valvulopat&iacute;a mitral degenerativa y funcional, aspectos    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;comunes y diferenciales&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Nojek (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;Casos Cl&iacute;nicos&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Rodrigo Abreu&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estratificaci&oacute;n de riesgo en la insuficiencia mitral: desde el paciente  asintom&aacute;tico a la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;intervenci&oacute;n&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Dra. Catherine Otto (USA)</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Alvaro Beltr&aacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa SUC - Sociedad Sudamericana de Cardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Algoritmo diagn&oacute;stico en las miocardiopat&iacute;as&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Carlos Gonz&aacute;lez Tr&iacute;as, Dr. Nelson Pizzano</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidentes: Dra. M&oacute;nica Giambruno, Dr. Rafael Arcos (Ecuador)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.50&nbsp;&nbsp;&nbsp;&nbsp;Aspectos cl&iacute;nicos de las miocardiopat&iacute;as no isqu&eacute;micas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Juan Alonso&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.50 &ndash; 11.10&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Qu&eacute; nos aporta el ecocardiograma en el estudio de las miocardiopat&iacute;as     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;no isqu&eacute;micas?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Le&oacute;n Mu&ntilde;oz&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.10 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;Valor agregado del estudio de las MNI mediante resonancia  card&iacute;aca y TAC     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;multicorte&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Obreg&oacute;n (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 11.50&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento de las miocardiopat&iacute;as&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jorge Estigarribia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.50 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Estrategias diagn&oacute;sticas en las miocardiopat&iacute;as&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. C&eacute;sar Belziti (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Luis Vidal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Simposio Bayer&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Es posible manejar la enfermedad tromboemb&oacute;lica arterial y venosa con  un solo     <br>  &nbsp;&nbsp;&nbsp;&nbsp;anticoagulante?&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b>Coordinador: Dr. Gonzalo Varela</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.30 &ndash; 12.35&nbsp;&nbsp;&nbsp;&nbsp;Rivaroxaban: de la enfermedad tromboemb&oacute;lica venosa a la     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enfermedad  arterial coronaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Santiago Pomoli&nbsp; </font></p>       <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.35 &ndash; 12.50&nbsp;&nbsp;&nbsp;&nbsp;Rivaroxaban en fibrilaci&oacute;n auricular: de los estudios cl&iacute;nicos a la pr&aacute;ctica diaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Walter Reyes Caorsi&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.50 &ndash; 13.10&nbsp;&nbsp;&nbsp;&nbsp;Una nueva era en la prevenci&oacute;n secundaria del SCA. Estudio Atlas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.10 &ndash; 13.20&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;13.20 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Lunch cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Isquemia silente. Marcadores de riesgo, Estudios funcionales&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Federico Ferrando, Dra. Mariela Lujambio</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.10&nbsp;&nbsp;&nbsp;&nbsp;Bases fisiol&oacute;gicas de la isquemia mioc&aacute;rdica sin manifestaciones cl&iacute;nicas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Roberto Ricca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.10 &ndash; 14.20&nbsp;&nbsp;&nbsp;&nbsp;El razonamiento cl&iacute;nico pr&aacute;ctico ante el paciente con isquemia silente&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Washington Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.20 &ndash; 14.30&nbsp;&nbsp;&nbsp;&nbsp;Utilidad de las t&eacute;cnicas de imagenolog&iacute;a nuclear en el algoritmo diagn&oacute;stico de    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;la isquemia silente&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Miguel Kapit&aacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 &ndash; 14.40&nbsp;&nbsp;&nbsp;&nbsp;Aportes de la RNM al estudio del paciente con isquemia silente&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gabriel Parma, Dra. Natalia Lluberas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.40 &ndash; 14.50&nbsp;&nbsp;&nbsp;&nbsp;Estrategias diagn&oacute;sticas y terap&eacute;uticas coronarias invasivas en la isquemia    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;silente&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo V&aacute;zquez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.50 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.25&nbsp;&nbsp;&nbsp;&nbsp;Isquemia silente, marcadores de riesgo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Pi&ntilde;eiro (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;15.25 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>       <p><font face="Verdana" size="2"> 15.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Conference<b>&nbsp;</b>    <br> &nbsp;&nbsp;    ]]></body>
<body><![CDATA[<br> </font> </p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Conference&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 09.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa &nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Manejo del paciente luego de un evento coronario agudo&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dr. Sergio C&aacute;ceres, Dr. Sergio Meirelles&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.05&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Sergio C&aacute;ceres, Dr. Sergio Meirelles&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.05 &ndash; 08.25&nbsp;&nbsp;&nbsp;&nbsp;Estratificaci&oacute;n de riesgo en pacientes sin anatom&iacute;a coronaria conocida&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Washington Vignolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.25 &ndash; 08.45&nbsp;&nbsp;&nbsp;&nbsp;Seguimiento cl&iacute;nico de los pacientes tratados con angioplastia coronaria post    ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;stent con droga&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jorge Belardi (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;08.45 &ndash; 09.05&nbsp;&nbsp;&nbsp;&nbsp;Uso de los nuevos antiagregantes plaquetarios en los SCA:  &iquest;cu&aacute;l, a qui&eacute;n, cu&aacute;ndo?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. H&eacute;ctor Bueno (Espa&ntilde;a)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.05 &ndash; 09.25&nbsp;&nbsp;&nbsp;&nbsp;Doctor: &iquest;puedo volver a trabajar? Riesgo, consejo y tratamiento luego del alta    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sanatorial&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Luc&iacute;a Florio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;09.25 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;Preguntas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Conferencia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Infrautilizaci&oacute;n de aspirina en la prevenci&oacute;n secundaria de la ECV&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. H&eacute;ctor Bueno (Espa&ntilde;a)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dra. Mar&iacute;a del Pilar Aguilar&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Mesa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Actualizaci&oacute;n en el uso de f&aacute;rmacos en prevenci&oacute;n 1&ordf;. y 2&ordf;. Hemodinamia  y metabolismo&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Auspicia: Urufarma&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Dra. Florencia Maglione, Dr. Jos&eacute; Anibal Manfredi&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.35&nbsp;&nbsp;&nbsp;&nbsp;Apertura&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Jos&eacute; Anibal Manfredi, Dra. Florencia Maglione&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.35 &ndash; 10.50&nbsp;&nbsp;&nbsp;&nbsp;Betabloqueantes S&iacute; o No&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Bernardo Layerle&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.50 &ndash; 11.05&nbsp;&nbsp;&nbsp;&nbsp;Estatina: &iquest;a qui&eacute;nes y cu&aacute;nto?    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ra&uacute;l Pisabarro&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.05 &ndash; 11.20&nbsp;&nbsp;&nbsp;&nbsp;Preguntas frecuentes&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.20 &ndash; 11.40&nbsp;&nbsp;&nbsp;&nbsp;Uso en cardiolog&iacute;a de los inhibidores de la fosfodiesterasa 5 (cardiolog&iacute;a y    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;sexualidad)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Pi&ntilde;eiro (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.40 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento m&eacute;dico de la enfermedad arterial coronaria cr&oacute;nica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Robert Bonow (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio Novartis &ndash; Gram&oacute;n Bag&oacute;&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novedades de las gu&iacute;as europeas de HTA 2013&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Pi&ntilde;eiro (Argentina)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinador: Dr. Bernardo Layerle&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad en Ball Room A<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Mesa&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Trabajos Premiados&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Horacio V&aacute;zquez</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Tribunal: Dr. H&eacute;ctor Bueno (Espa&ntilde;a), Dr. Marcelo Di Carli (USA), Dr. Juan  Viles Gonz&aacute;lez (USA),    <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Carlos Nojek (Argentina), Dr. Carlos Romero&nbsp; </font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;3&nbsp;&nbsp;&nbsp;&nbsp;La aplicaci&oacute;n de planificaci&oacute;n estrat&eacute;gica y de herramientas gen&eacute;ricas     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ISO 9001:2008 en el control integral de los factores de riesgo para     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;enfermedad cardiovascular, determinan una mayor tasa de &eacute;xito a largo    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;plazo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. V&iacute;ctor Martire&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 &ndash; 14.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;28&nbsp;&nbsp;&nbsp;&nbsp;&iquest;Es la glicemia intraoperatoria un marcador pron&oacute;stico en cirug&iacute;a     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;card&iacute;aca en pacientes no diab&eacute;ticos?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Figueroa&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.30 &ndash; 14.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;40&nbsp;&nbsp;&nbsp;&nbsp;Elevados niveles de Interfer&oacute;n gamma e interleuquina-10 en el     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ambiente intracoronario de pacientes con s&iacute;ndrome coronario agudo con    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;elevaci&oacute;n del ST&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Natalia Lluberas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.45 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;49&nbsp;&nbsp;&nbsp;&nbsp;Evaluaci&oacute;n del tama&ntilde;o de infarto mediante resonancia magn&eacute;tica     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;card&iacute;aca y su asociaci&oacute;n con la circulaci&oacute;n colateral&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Natalia Lluberas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;52&nbsp;&nbsp;&nbsp;&nbsp;Resucitaci&oacute;n con DEA en el Uruguay&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Fernanda Xalambr&iacute;&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.15 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;60&nbsp;&nbsp;&nbsp;&nbsp;Ateromatosis carotidea y caracter&iacute;sticas de tratamiento en pacientes con    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;disfunci&oacute;n sist&oacute;lica de etiolog&iacute;a no isqu&eacute;mica: comparaci&oacute;n con     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;poblaci&oacute;n control&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Juan Sebasti&aacute;n Albistur&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 &ndash; 15.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;73&nbsp;&nbsp;&nbsp;&nbsp;El abuso cr&oacute;nico de clorhidrato y pasta base de coca&iacute;na asocia     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;envejecimiento arterial y aumento del riesgo cardiovascular en j&oacute;venes    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;asintom&aacute;ticos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Miguel Kapit&aacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 16.30 &ndash; 17.00<b>&nbsp;&nbsp;&nbsp;&nbsp;Conferencia de clausura&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Avances y desaf&iacute;os en imagenolog&iacute;a cardiovascular&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Dr. Robert Bonow (USA)&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Presidente: Dr. Gustavo Junker&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 17.00 &ndash; 19.00&nbsp;&nbsp;&nbsp;&nbsp;<b>4as. Jornadas Rioplatenses de Cardi&oacute;logos en Formaci&oacute;n (CCFUR  &ndash; CONAREC)&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;CardiOlimp&iacute;adas&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i><b>&nbsp;&nbsp;&nbsp;&nbsp;</b></i>Coordinadores: Dra. Natalia Esmite, Dra. Luciana Jubany, Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Gabriel Parma, Dr. Gustavo Tortajada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Participantes: Dr. Sebasti&aacute;n Albistur, Dr. Oscar Bazzino, Dr. Evaristo  Castellano (Argentina),     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Diego Crippa (Argentina), Dra. Romina Daganutto  (Argentina), Dra. Marcela Delpiano,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dr. Pablo D&iacute;az, Dra. Diana Sasso, Dr.  Gonzalo Varela&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 19.00 &ndash; 19.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Entrega de Premios&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Mejor Tema Libre&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado e inscripci&oacute;n al Congreso Espa&ntilde;ol de Cardiolog&iacute;a 2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Premio Pfizer: Mejor Tema Libre al Investigador Joven&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, inscripci&oacute;n y alojamiento al Congreso Espa&ntilde;ol de Cardiolog&iacute;a  2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Tema Libre Destacado 1&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Tema Libre Destacado 2&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Tema Libre Destacado 3&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Tema Libre Destacado 4&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2014&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Tema Libre Destacado 5&nbsp;</b> </font></p>       ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Traslado, alojamiento e inscripci&oacute;n al Congreso Argentino de Cardiolog&iacute;a  2014&nbsp;    <br> &nbsp;</font></p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Picasso&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<b>Comit&eacute; de Prevenci&oacute;n y Rehabilitaci&oacute;n Cardiovascular&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Rehabilitaci&oacute;n card&iacute;aca: una visi&oacute;n integradora. An&aacute;lisis de casos cl&iacute;nicos</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Dra. Mar&iacute;a Dutra</i>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Panelistas: Dr. Nicol&aacute;s Arrieta, Dr. Oscar Bazzino, Dr. Gerard Burdiat,  Dr. Ricardo Lluberas,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;Dra. Florencia Maglione&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Pausa activa&nbsp;</b> </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>Simposio&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comit&eacute; de Prevenci&oacute;n y Rehabilitaci&oacute;n Cardiovascular (Cont.)</b>&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;Actividad f&iacute;sica: la mejor prescripci&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Oscar D&iacute;az Arnesto&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prescripci&oacute;n del ejercicio, entre la &eacute;tica y la productividad&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dra. Cecilia del Campo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prescripci&oacute;n diet&eacute;tica: los cambios iniciales&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Nut. Patricia Jansons&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Creencias implicadas en los procesos de cambio y en la adherencia al     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;tratamiento  en pacientes cardiovasculares&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Ps. Lorena Stefanell&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;Corrida, sexo y coraz&oacute;n: una charla en la capital charr&uacute;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Ricardo Stein (Brasil)&nbsp;</font></p>     <p align="left">&nbsp;</p>       <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: C&eacute;zanne&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;<b>Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <b>&nbsp;&nbsp;&nbsp;&nbsp;Hemodinamia&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. C&eacute;sar Pardi&ntilde;as, Dr. Fernando Kuster&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;48&nbsp;&nbsp;&nbsp;&nbsp;Tratamiento paliativo de la estenosis valvular a&oacute;rtica severa en una serie    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de pacientes cr&iacute;ticos y de alto riesgo quir&uacute;rgico: valvuloplastia a&oacute;rtica    ]]></body>
<body><![CDATA[<br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;percut&aacute;nea con bal&oacute;n&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Ignacio Batista&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.15 &ndash; 08.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;64&nbsp;&nbsp;&nbsp;&nbsp;Angioplastia coronaria en pacientes trasplantados card&iacute;acos &nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 &ndash; 08.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;65&nbsp;&nbsp;&nbsp;&nbsp;Registro IVUS. Impacto de la ultrasonograf&iacute;a intracoronaria en un servicio    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de cardiolog&iacute;a intervencionista. Experiencia inicial&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.45 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;70&nbsp;&nbsp;&nbsp;&nbsp;Revascularizaci&oacute;n secundaria en pacientes con cirug&iacute;a de     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;revascularizaci&oacute;n mioc&aacute;rdica previa e indicaci&oacute;n de CACG diagn&oacute;stica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Lluberas&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;71&nbsp;&nbsp;&nbsp;&nbsp;Propuesta de par&aacute;metros objetivos de evaluaci&oacute;n de la extensi&oacute;n y     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;severidad de la enfermedad coronaria basados en el Score Syntax&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Sebasti&aacute;n Guerra&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.15 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;72&nbsp;&nbsp;&nbsp;&nbsp;Neoateromatosis coronaria: una nueva causa de infarto agudo de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;miocardio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Santiago Alonso&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30<b>&nbsp;&nbsp;&nbsp;&nbsp;Presentaci&oacute;n E-posters&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;</i><b>Im&aacute;genes&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dra. Susana Zeffiro (Argentina), Dr. Juan Bautista Gonz&aacute;lez  Moreno&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 10.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;1&nbsp;&nbsp;&nbsp;&nbsp;Concordancia entre los estudios de perfusi&oacute;n mioc&aacute;rdica con dipiridamol    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;y test de doble f&aacute;rmaco combinando dipiridamol con adenosina en bajas    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dosis&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Victor Martire&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.45 &ndash; 11.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;6&nbsp;&nbsp;&nbsp;&nbsp;Significado cl&iacute;nico de estudios de perfusi&oacute;n mioc&aacute;rdica normal por SPECT    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;con electrocardiograma de estr&eacute;s positivo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Miguel Hominal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.00 &ndash; 11.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;10&nbsp;&nbsp;&nbsp;&nbsp;Dimensiones y valores del complejo A&oacute;rtico en poblaci&oacute;n sana uruguaya&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.15 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;11&nbsp;&nbsp;&nbsp;&nbsp;Factibilidad y reproducibilidad intra e interobservador de strain     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;longitudinal global por m&eacute;todo &ldquo;vector velocity imaging&rdquo; en una     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;poblaci&oacute;n adulta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Gabriel Parma&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 11.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;32&nbsp;&nbsp;&nbsp;&nbsp;Variabilidad y reproducibilidad de medidas por ecocardiograf&iacute;a     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;transtor&aacute;cica es adecuada en la vida real de un laboratorio de     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ecocardiograf&iacute;a &nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Fabi&aacute;n Mart&iacute;nez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;Comentadores: Dr. Mario Beretta, Dr. Gustavo Tamosiunas&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;11.45 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;33&nbsp;&nbsp;&nbsp;&nbsp;Ateromatosis a&oacute;rtica potencialmente embol&iacute;gena: topograf&iacute;a y valor    <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;diagn&oacute;stico del ecocardiograma transtor&aacute;cico&nbsp; </font></p>       ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Fabi&aacute;n Mart&iacute;nez&nbsp;&nbsp;</font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.00 &ndash; 12.15&nbsp;&nbsp;&nbsp;&nbsp;N&deg;36&nbsp;&nbsp;&nbsp;&nbsp;Efectos de la isquemia mioc&aacute;rdica sobre la disincron&iacute;a mec&aacute;nica     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;intraventricular izquierda en pacientes con trastornos de la conducci&oacute;n    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;intraventricular  y funci&oacute;n contr&aacute;ctil conservada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Alejandro Vidal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.15 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;N&deg;37&nbsp;&nbsp;&nbsp;&nbsp;Potencial impacto de la isquemia mioc&aacute;rdica severa sobre la disincron&iacute;a     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;mec&aacute;nica del VI en presencia de BCRD avanzado&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Federico Ferrando&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.30 &ndash; 12.45&nbsp;&nbsp;&nbsp;&nbsp;N&deg;62&nbsp;&nbsp;&nbsp;&nbsp;El supradesnivel del segmento ST en aVR se asocia a mayor riesgo     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;isqu&eacute;mico en el SPECT de perfusi&oacute;n mioc&aacute;rdica&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentadora: Dra. Mariela Lujambio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;12.45 &ndash; 13.00&nbsp;&nbsp;&nbsp;&nbsp;N&deg;63&nbsp;&nbsp;&nbsp;&nbsp;Ser familiar de pacientes con v&aacute;lvula a&oacute;rtica bic&uacute;spide no representa un     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;riesgo adicional en el di&aacute;metro de la aorta ascendente&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Presentador: Dr. Pablo Straneo&nbsp;&nbsp;</font></p>     <p align="left">&nbsp;</p>     <p align="left"><font face="Verdana" size="2"> <b>Sal&oacute;n: Ball Room C&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 08.00 &ndash; 10.00<b>&nbsp;&nbsp;&nbsp;&nbsp;XIV Jornadas de Enfermer&iacute;a en Cardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;<i>Coordinadora: Lic. Gessy Dos Santos&nbsp;</i> </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.00 &ndash; 08.30&nbsp;&nbsp;&nbsp;&nbsp;Pautas de prevenci&oacute;n en salud cardiovascular. Puesta a punto&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Virginia Oxley&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;08.30 &ndash; 09.00&nbsp;&nbsp;&nbsp;&nbsp;Actividad f&iacute;sica en pacientes de un programa de prevenci&oacute;n secundaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Jorge Tejada&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.00 &ndash; 09.30&nbsp;&nbsp;&nbsp;&nbsp;Estudio de conocimiento y pr&aacute;cticas alimenticias en un grupo de enfermeros de    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;la ciudad de Montevideo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Cristina Rodr&iacute;guez, Lic. Gabriela Dotti&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;09.30 &ndash; 10.00&nbsp;&nbsp;&nbsp;&nbsp;Procedimientos con v&aacute;lvulas card&iacute;acas. INDT&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. Mariana Vals, Lic. Mar&iacute;a Acosta&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 10.00 &ndash; 10.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 10.30 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;<b>XIV Jornadas de Enfermer&iacute;a en Cardiolog&iacute;a &ndash; Continuaci&oacute;n&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;10.30 &ndash; 11.00&nbsp;&nbsp;&nbsp;&nbsp;Por qu&eacute; se pierden potenciales donantes card&iacute;acos&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Mario Godino&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.00 &ndash; 11.30&nbsp;&nbsp;&nbsp;&nbsp;Trasplante card&iacute;aco: riesgo post operatorio&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Daniel Chafes&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;11.30 &ndash; 12.00&nbsp;&nbsp;&nbsp;&nbsp;Insuficiencia card&iacute;aca. Adherencia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ps. Silvana Spagnuolo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;12.00 &ndash; 12.30&nbsp;&nbsp;&nbsp;&nbsp;Asociaci&oacute;n de Trasplantados del Uruguay. ATUR&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Sr. Miguel Sluckis&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 12.30 &ndash; 14.00&nbsp;&nbsp;&nbsp;&nbsp;Intervalo<b>&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> 14.00 &ndash; 16.00<b>&nbsp;&nbsp;&nbsp;&nbsp;XX Encuentro de Neumocardiolog&iacute;a&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2"> <i>&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Lic. NC. Mart&iacute;n Acu&ntilde;a</i>&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;14.00 &ndash; 14.15&nbsp;&nbsp;&nbsp;&nbsp;Apertura&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Gustavo Junker: Presidente Congreso&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Mart&iacute;n Acu&ntilde;a: Presidente Comit&eacute;&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;14.15 &ndash; 15.00&nbsp;&nbsp;&nbsp;&nbsp;ECG en la pr&aacute;ctica: C&oacute;mo interpretarlo y no fracasar en el intento II&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadores: Lic. NC. Cristina Ekroth, Lic. NC. Pablo Marichal&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Germ&aacute;n Iriart, Br. Cecilia Rosso, Br. Agustina Vece,     <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Br. Dahiana Claveri, Br. Daiana Cambio, Br. Gimena P&eacute;rez, Br. Flavia Garc&iacute;a,     <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Br. Elena Iraztorsa&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.00 &ndash; 15.30&nbsp;&nbsp;&nbsp;&nbsp;Monitorizaci&oacute;n ECG ambulatoria: &iquest;qu&eacute; sucede despu&eacute;s de realizar el Holter?&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Luis A. Noya&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Pablo Marichal, Lic. NC. Eugenia Garc&iacute;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;15.30 &ndash; 16.00&nbsp;&nbsp;&nbsp;&nbsp;Hemodin&aacute;mica: m&aacute;s all&aacute; de la enfermedad coronaria&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Dr. Pedro Trujillo&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Leonardo De Le&oacute;n, Lic. NC. Natalie Marozzi&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> 16.00 &ndash; 16.30&nbsp;&nbsp;&nbsp;&nbsp;Caf&eacute;: Cortes&iacute;a Bayer&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> <b>16.30 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;XX Encuentro de Neumocardiolog&iacute;a &ndash; Continuaci&oacute;n&nbsp;</b> </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;16.30 &ndash; 17.00&nbsp;&nbsp;&nbsp;&nbsp;Radiolog&iacute;a de t&oacute;rax, generalidad y patolog&iacute;as&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinador: Lic. NC. Mart&iacute;n Acu&ntilde;a&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Guillermo Campos, Lic. Victoria Serrano&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.00 &ndash; 17.15&nbsp;&nbsp;&nbsp;&nbsp;Reclasificaci&oacute;n del riesgo cardiovascular en una poblaci&oacute;n uruguaya     ]]></body>
<body><![CDATA[<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;asintom&aacute;tica mediante utilizaci&oacute;n de estudios arteriales no invasivos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Noelia de Pati&nbsp; </font></p>       <p><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositor: Lic. NC. Marcelo Berm&uacute;dez&nbsp;&nbsp;</font></p>     <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.15 &ndash; 17.30&nbsp;&nbsp;&nbsp;&nbsp;Eficacia de la terapia de resincronizaci&oacute;n en pacientes con insuficiencia card&iacute;aca&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Ana Umpi&eacute;rrez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Eugenia Garc&iacute;a, Lic. NC. Guillermo Campos&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;17.30 &ndash; 17.45&nbsp;&nbsp;&nbsp;&nbsp;Valor diagn&oacute;stico de score de Atenas en la cardiopat&iacute;a isqu&eacute;mica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordinadora: Lic. NC. Blanca Mart&iacute;nez&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expositores: Lic. NC. Daniela Umpi&eacute;rrez, Lic. NC. Gonzalo Decia&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;17.45 &ndash; 18.00&nbsp;&nbsp;&nbsp;&nbsp;Clausura&nbsp; </font></p>      ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Graciela Domato: Directora Escuela Tecnolog&iacute;a M&eacute;dica&nbsp; </font></p>      <p align="left"><font face="Verdana" size="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lic. NC. Noelia De Patti: Secretaria Comit&eacute; de Neumocardiolog&iacute;a    <br>  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Autoridades  de ATENCU&nbsp; </font></p>   <font face="Verdana" size="2">       <br>  </font>       ]]></body>
</article>
